Item 5. OTHER INFORMATION

During the three months ended July 31, 2024, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) informed us of the adoption or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K), except as follows. On June 6, 2024, Sundeep Reddy, Executive Vice President and Chief Accounting Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 2,000 shares of the Company’s common stock, subject to certain conditions, through December 31, 2025 (or the date all shares are sold under the arrangement, if earlier). On June 12, 2024, Sabastian Niles, President and Chief Legal Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 11,774 shares of the Company’s common stock, subject to certain conditions, through June 30, 2025 (or the date all shares are sold under the arrangement, if earlier). On June 24, 2024, Maynard Webb, Director, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 9,170 shares of the Company’s common stock, subject to certain conditions, through September 26, 2025 (or the date all shares are sold under the arrangement, if earlier). On June 28, 2024, David Schmaier, President and Chief Product Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 7,140 shares of the Company’s common stock, subject to certain conditions, through June 30, 2025 (or the date all shares are sold under the arrangement, if earlier).